중국 병원 및 약국 시장 – 2030년까지의 산업 동향 및 예측

중국 병원 및 약국 시장 분석 및 규모

병원에서 건강 검진에 사용되는 로봇 보조 시스템과 같은 의료 자동화 기술에 대한 수요가 증가하고 대량으로 도입됨에 따라 시장 성장이 촉진되어 환자 안전이 개선될 것으로 예상됩니다. 최근 들어 중국 제약 및 투자 회사가 해외에서 여러 합병 및 인수에 광범위하게 참여하면서 시장의 국제화 진전이 증가하고 있습니다. 중국의 여러 제약 제조업체는 주로 기본 화학 물질, 중간체 및 활성 제약 성분(API) 생산에 주력하고 있으며, 중국에는 약 4,000개의 API 제조업체가 있습니다.

 Data Bridge Market Research는 2023-2030년 예측 기간 동안 병원 및 약국 시장의 성장률을 분석합니다. 병원 및 약국 시장의 예상 CAGR은 언급된 예측 기간 동안 약 12.5%인 경향이 있습니다. 시장은 2022년에 1,471.23백만 달러로 평가되었으며 2030년까지 3,774.85백만 달러로 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

중국 병원 및 약국 시장 범위 및 세분화

시장 정의

병원과 약국은 환자의 신체에서 비정상적인 변화를 감지하고 건강을 지원하기 위한 더 나은 치료 계획을 수립하도록 돕습니다. 여기에는 의료적 실수를 줄이고 수많은 만성 질환을 더 잘 관리하는 데 사용되는 기술이 포함됩니다. 병원은 모니터링, 진단 및 치료 과정을 담당하며, 의료 제공자는 수많은 의료 시설에서 주요 대응 작업을 수행합니다.

중국 병원 및 약국 시장 역학

운전자

• 약물 분배 시스템 채택 증가

약물 분배 시스템은 시장 성장을 더 크게 이끌었습니다. 높은 점유율은 약물 분배의 정확성과 이러한 시스템이 제공하는 향상된 안전성으로 인해 환자에게 잘못된 약물이 분배되는 사례가 줄어들었기 때문입니다. 환자에게 잘못된 약물을 투여하면 건강에 해를 끼치고 발생하는 비용에 큰 영향을 미친다는 것이 입증되었습니다. StatPearls의 연구 기사에 따르면 매년 약 9,000명이 약물 오류로 인해 사망하고 환자 관리 측면에서 약물 오류와 관련된 비용은 매년 400억 달러가 넘습니다. 따라서 이 요인은 시장 성장을 촉진합니다.

• 제네릭 의약품의 성장 증가

The area of generic medicines is letting the market grow rapidly. Generic medicines include anti-infection drugs, cardiovascular system drugs, anti-tumor, cancer drugs, and several drugs for the digestive system. Generic drugs are found to be the mainstay of China's pharmaceutical industry. The revenue is anticipated to increase strongly in upcoming years because of its large market demand. China will use generics to reduce total healthcare expenditures in its public insurance plan. Thus, this increasing growth of generic medicines is enhancing the market growth.

Opportunities

• Growing Demand For Retail Pharmacies

The growing demand for retail pharmacies, among other end-users of this market, led to the market's growth. This can be attributed to a rise in retail pharmacies in this region. Automation in retail pharmacies leads to the reduction of costs at multiple levels. For instance, the OECD library states that the number of pharmacies has increased across all the OECD companies. Thus, this factor increases the market growth.

• Expansion of Pharmaceutical Industries and their Associated Medicinal Products

The pharmaceutical manufacturing industry of China witnessed huge growth when the country was relatively isolated from international trade. In 2021, China will have more than 5,000 pharmaceutical manufacturers, and the Government is strongly encouraging the consolidation of the pharmaceutical industry, particularly to decrease the number of smaller companies that do not have the financial capacity to meet several new regulatory standards. Chinese pharmaceutical manufacturers have focused on producing intermediates, basic chemicals, and active pharmaceutical ingredients (APIs), with approximately 4,000 API manufacturers in the country. It has been witnessed that within a short time, China has become the top global supplier of APIs in terms of volume. Thus, this factor increases the market growth.

Restraints/Challenges

• Increased Production Costs

The increased expenditure associated with the manufacturing of medicines hinders market growth. Growing production costs because of stricter production standards and ecological regulations is uplifting the cost price of the process. The increased cost related to manufacturing, supply and hospitals and pharmacy is not possible many times for developing and underdeveloped countries, which leads to the undertreatment of numerous patients. This impedes market growth.

This hospitals and pharmacy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hospitals and pharmacy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2020, Ai Linghang, launched by Shanghai Qiyou Precision Electromechanical Co., Ltd., was showcased at the Arab Health 2020 held in Dubai. The people witnessed the new technologically sound pill packaging machine combined with a pill box and an alarm system which will reduce the huge pill packaging process.

China Hospitals and Pharmacy Market Scope

The hospitals and pharmacy market is segmented on the basis of component, type, application, connectivity, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Component  

• Equipment
• Software and Services

Type

• Automated Prescription Formulation and Dispensing
• Automated Health Assessment and Monitoring
• Automated Imaging and Image Analysis
• Automated Healthcare Logistics
• Resource and Personnel Tracking
• Medical Robotics and Computer-Assisted Surgical Devices
• Automated Therapeutic (Nonsurgical) Procedures
• Automated Laboratory Testing and Analysis 

Application

• Diagnostics & Monitoring
• Therapeutics
• Lab & Pharmacy Automation
• Medical Logistics & Training
• Others

Connectivity

• Wired
• Wireless

End User

• Hospitals
• Pharmacies

Distribution Channel

• Direct Tender
• Retail Sales
•  Online Sales
• Others

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The hospitals and pharmacy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hospitals and pharmacy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hospitals and pharmacy market. The data is available for historic period 2011-2021.

Competitive Landscape and China Hospitals and Pharmacy Market Share Analysis

The hospitals and pharmacy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, China presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hospitals and pharmacy market

Key players operating in the hospitals and pharmacy market include:

• Baxter (U.S.)
• Takazono Corporation (Japan)
• TOSHO CO., INC.(Japan)
• YUYAMA Co.,Ltd / YUYAMA MFG Co.,Ltd (Japan)
• Shandong New Beiyang Information Technology Co., Ltd (China)
• Asahi Kasei Corporation (Tokyo)
• Intuitive Surgical (U.S.)
• Medtronic (Ireland)
• Stryker (U.S.)
• Omnicell, Inc (U.S.)
• B.D. (U.S.)
• Siemens Healthcare GmbH (Germany)
• Koninklijke Philips N.V.(Netherlands)
• G.E. Healthcare (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)

SKU-60774